Voichita Bar‐Ad

Oral cavity and oropharyngeal squamous cell carcinoma—an update

Head and neck squamous cell carcinoma

A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma

Management of borderline and locally advanced pancreatic cancer: Where do we stand?

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy

Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment

Pancreatic cancer

Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma

Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature

Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer

Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites

Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy

The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy

Safety and cost analysis of an 18FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation

Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release

Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents

Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science

HDACs and HDAC Inhibitors in Cancer Development and Therapy

Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy

Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas

Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial

Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy

FDG-PET,a Complementary Modality to Computed Tomography in Radiotherapy Target Volume Delineation for Head and Neck Cancer

Locally Advanced Pancreatic Cancer

Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma

Positron Emission Tomography for Neck Evaluation Following Definitive Treatment with Chemoradiotherapy for Locoregionally Advanced Head and Neck Squamous Cell Carcinoma